Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Dental Caries
Interventions
DRUG

C16G2

Antimicrobial peptide

OTHER

Placebo

Placebo

Trial Locations (5)

10010

New York University College of Dentistry, New York

19104

University of Pennsylvania School of Dental Medicine, Philadelphia

46202

Indiana University School of Dentistry, Indianapolis

59901

John F. Pittaway, DMD, Kalispell

75063

Anthony Henegar, DDS, PA, Irving

Sponsors
All Listed Sponsors
lead

Armata Pharmaceuticals, Inc.

INDUSTRY